Literature DB >> 7891866

Effect of in utero ethanol exposure on the postnatal ontogeny of insulin-like growth factor-1, and type-1 and type-2 insulin-like growth factor receptors in the rat brain.

C R Breese1, A D'Costa, W E Sonntag.   

Abstract

There is convincing evidence that alcohol consumption during pregnancy causes major CNS abnormalities; however, the molecular and cellular basis of these dysfunctions is currently not understood. This study examined the effects of prenatal ethanol exposure on the expression of insulin-like growth factor-1 messenger RNA and type-1 and type-2 receptor protein and messenger RNA expression in the developing rat brain. Mothers were maintained on an ethanol containing liquid diet from day 2 of pregnancy through parturition and the offspring were killed at birth, 10, 20 and 40 days of age. Insulin-like growth factor-1 messenger RNA, and insulin-like growth factor receptors demonstrated developmentally dependent expression in specific brain regions throughout the postnatal period of CNS maturation. Insulin-like growth factor-1 gene expression in the brain, as analysed by dot-blot hybridization, was greatest at birth, and decreased 61% in ad libitum and pair-fed animals by 20 days of age. In contrast, ethanol-treated animals exhibited only a 25% decrease in insulin-like growth factor-1 messenger RNA levels during the same period. This delay in insulin-like growth factor-1 messenger RNA maturation may be related to a developmental delay in CNS development in the prenatally ethanol exposed offspring. Prenatal ethanol exposure did not alter the observed localization of insulin-like growth factor-1 messenger RNA. While alterations were observed in long-term insulin-like growth factor-1 messenger RNA regulation, quantitative receptor autoradiography and in situ hybridization demonstrated no alterations in either type-1 or type-2 insulin-like growth factor receptor populations in ethanol-treated animals. Changes in hepatic and plasma insulin-like growth factor-1 and insulin-like growth factor-binding protein regulation have also been observed in these animals, suggesting changes in protein translation and the autocrine/paracrine actions of this peptide. The present study demonstrated that insulin-like growth factor-1 messenger RNA and insulin-like growth factor receptors are regionally expressed during early postnatal development and that ethanol administration influenced the long-term regulation of insulin-like growth factor messenger RNA levels in the brain without affecting either its localization or insulin-like growth factor receptor populations.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7891866     DOI: 10.1016/0306-4522(94)90551-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Regional gene expression of the glutamate receptor subtypes GluR1, GluR2, and GluR3 in human postmortem brain.

Authors:  C R Breese; J Logel; C Adams; S S Leonard
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

2.  Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells.

Authors:  C J Frazier; Y D Rollins; C R Breese; S Leonard; R Freedman; T V Dunwiddie
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

Review 3.  Role of central nervous system insulin resistance in fetal alcohol spectrum disorders.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Popul Ther Clin Pharmacol       Date:  2010-10-26

4.  Prenatal ethanol exposure disrupts the histological stages of fetal bone development.

Authors:  M E Snow; K Keiver
Journal:  Bone       Date:  2007-04-25       Impact factor: 4.398

5.  si-RNA inhibition of brain insulin or insulin-like growth factor receptors causes developmental cerebellar abnormalities: relevance to fetal alcohol spectrum disorder.

Authors:  Suzanne M de la Monte; Ming Tong; Nathaniel Bowling; Peter Moskal
Journal:  Mol Brain       Date:  2011-03-28       Impact factor: 4.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.